Notably, the bulk tumor cells obtained from the TSD negative CTC group displayed a 6-7-fold lower proportion of pimonidazole-positive cells compared to the TSD positive CTC group (p<0.02; Supplementary Figure S4A). This evidence concerns the gene HEXA and neoplasm.